| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Brain Tumor Intraoperative Ultrasound Database (NCT05062772) | Hospital del Rio Hortega | 2022-05-25 |
| Pembro+Chemo in Brain Mets (NCT04964960) | John L. Villano, MD, PhD | 2022-05-19 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Controlling Coordination After Childhood Cerebellar Cancer, a Pilot Study (NCT04501731) | University of Nottingham | 2022-04-28 |
| Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM (NCT05271240) | Northwell Health | 2022-04-27 |
| Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors (NCT05169944) | University of California, San Francisco | 2022-04-22 |
| Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery (NCT04689048) | Baptist Health South Florida | 2022-04-04 |
| The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors (NCT05116137) | Nova Scotia Health Authority | 2022-03-01 |
| Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study (NCT04962672) | University Health Network, Toronto | 2022-01-01 |
| Wearable Devices and Biomarkers Project (Healthiomics) (NCT05106725) | CureScience | 2021-10-11 |
| Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases (NCT04899908) | Brigham and Women's Hospital | 2021-09-15 |
| Tempus Priority Study: A Pan-tumor Observational Study (NCT05179824) | Tempus AI | 2020-10-19 |
| Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. (NCT04367779) | Centre Leon Berard | 2020-09-24 |
| Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors (NCT04704804) | Institut Cancerologie de l'Ouest | 2020-07-24 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors (NCT04478279) | Sapience Therapeutics | 2020-07-01 |
| Single vs Multi-fraction SRS Patients on Immunotherapy (NCT04427228) | University of Chicago | 2020-06-29 |
| Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies (NCT05170087) | Sunnybrook Health Sciences Centre | 2020-03-02 |
| Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator (NCT04268979) | H. Lee Moffitt Cancer Center and Research Institute | 2020-02-13 |
| Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) (NCT04222309) | Northwell Health | 2020-01-06 |
| Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study (NCT04047602) | Indiana University | 2019-12-12 |
| PET and MRI Imaging of Brain Tumors Using [18F]PARPi (NCT04173104) | Memorial Sloan Kettering Cancer Center | 2019-11-01 |
| 3D Printed Mask for GBM and Brain Mets (NCT04114786) | University Health Network, Toronto | 2019-09-26 |
| Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors (NCT04023669) | St. Jude Children's Research Hospital | 2019-08-08 |
| Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas (NCT03925246) | Assistance Publique - Hôpitaux de Paris | 2019-07-30 |
| Neurosurgical Transitional Care Programme (NCT03593330) | Barts & The London NHS Trust | 2019-05-30 |
| The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. (NCT03861299) | Jasper Gerritsen | 2019-04-01 |
| Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors. (NCT03972514) | Baptist Health South Florida | 2019-03-08 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers (NCT03538587) | National Cancer Institute (NCI) | 2019-01-29 |
| Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM (NCT03630289) | Northwell Health | 2018-07-27 |
| Study to Develop Head Stabilizer for Use During Brain Radiation Therapy (NCT03629964) | University of Chicago | 2018-07-16 |
| T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery (NCT03190967) | National Cancer Institute (NCI) | 2018-04-18 |
| A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors (NCT03465618) | Memorial Sloan Kettering Cancer Center | 2018-03-07 |
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262) | St. Jude Children's Research Hospital | 2018-03-05 |
| Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression (NCT03050736) | Kintara Therapeutics, Inc. | 2017-12-17 |
| VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM (NCT03149575) | DelMar Pharmaceuticals, Inc. | 2017-10-27 |
| Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (NCT03294486) | Assistance Publique - Hôpitaux de Paris | 2017-10-12 |
| A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 (NCT03152318) | Dana-Farber Cancer Institute | 2017-07-18 |
| Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM (NCT03213002) | Northwell Health | 2017-06-13 |
| Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme (NCT03170141) | Shenzhen Geno-Immune Medical Institute | 2017-05-31 |
| Refining and Testing the Electronic Social Network Assessment Program (eSNAP) (NCT03026699) | H. Lee Moffitt Cancer Center and Research Institute | 2017-05-05 |
| Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma (NCT03072134) | Northwestern University | 2017-04-24 |
| Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting (NCT02717962) | Kintara Therapeutics, Inc. | 2017-01-20 |
| Re-craniotomy and Complications After Elective Neurosurgery (NCT03910556) | Chiang Mai University | 2017-01-01 |
| Safety Study of Afatinib for Brain Cancer (NCT02423525) | Santosh Kesari | 2016-12-01 |
| Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer (NCT02941536) | AC Camargo Cancer Center | 2016-11-01 |
| Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (NCT02798406) | DNAtrix, Inc. | 2016-10-06 |
| Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists (NCT02911155) | National Cancer Institute (NCI) | 2016-09-21 |
| A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma (NCT02852655) | Dana-Farber Cancer Institute | 2016-09-21 |
| Natural History of and Specimen Banking for People With Tumors of the Central Nervous System (NCT02851706) | National Cancer Institute (NCI) | 2016-09-01 |
| Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma (NCT02861898) | Northwell Health | 2016-06-01 |
| Early Life Exposures in Agriculture (NCT02743481) | National Cancer Institute (NCI) | 2016-04-14 |
| Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker (NCT02691923) | David W. Roberts | 2016-03-01 |
| An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) (NCT02617589) | Bristol-Myers Squibb | 2016-03-01 |
| Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) (NCT02808416) | Guangdong 999 Brain Hospital | 2016-03-01 |
| Biomarker Analysis of Central Nervous System Tumors (NCT02692898) | National Cancer Institute (NCI) | 2016-02-25 |
| IDH1 Peptide Vaccine for Recurrent Grade II Glioma (NCT02193347) | Katy Peters, MD, PhD | 2016-01-28 |
| More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery (NCT01445691) | Constantinos Hadjipanayis | 2015-11-01 |
| 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients (NCT02334722) | University of Florida | 2015-08-05 |
| Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis (NCT02457715) | Duke University | 2015-07-01 |
| Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS (NCT02452216) | Michael Iv | 2015-06-10 |
| Cambridge Brain Mets Trial 1 (NCT02768337) | Cambridge University Hospitals NHS Foundation Trust | 2015-03-10 |
| Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers (NCT02375841) | Memorial Sloan Kettering Cancer Center | 2015-02-01 |
| Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants (NCT02708056) | Baskent University | 2015-01-01 |
| PET Imaging of Intracranial Cancers With 18F-FSPG (NCT02370563) | Lantheus Biosciences Ltd. | 2014-11-01 |
| 18-F-Fluoroacetate as PET Imaging Agent (NCT01320787) | M.D. Anderson Cancer Center | 2014-10-01 |
| A Phase II Study of Dacomitinib in Progressive Brain Metastases (NCT02047747) | David Piccioni, M.D., Ph.D | 2014-02-01 |
| Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R (NCT02045368) | IGF Oncology, LLC | 2014-01-28 |
| Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis (NCT01974804) | Memorial Sloan Kettering Cancer Center | 2013-10-25 |
| Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas (NCT01849952) | Dartmouth-Hitchcock Medical Center | 2013-10-09 |
| Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors (NCT01902771) | Edward Ziga | 2013-09-03 |
| Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma (NCT01892397) | Memorial Sloan Kettering Cancer Center | 2013-06-01 |
| Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT) (NCT01854554) | M.D. Anderson Cancer Center | 2013-05-17 |
| Phase I/II Cabazitaxel for Recurrent Malignant Glioma (NCT01740570) | M.D. Anderson Cancer Center | 2013-04-01 |
| Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water (NCT01246869) | University of Utah | 2013-03-27 |
| Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01) (NCT01987193) | University of Florida | 2012-07-01 |
| Synchrotron Radiation to the Treatment of Intracranial Tumors (NCT01640509) | University Hospital, Grenoble | 2012-06-01 |
| CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII (NCT01454596) | National Cancer Institute (NCI) | 2012-05-16 |
| A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression (NCT01604512) | Memorial Sloan Kettering Cancer Center | 2012-05-01 |
| MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning (NCT01534104) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) (NCT01469247) | M.D. Anderson Cancer Center | 2011-12-07 |
| Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma (NCT01478178) | Kintara Therapeutics, Inc. | 2011-10-01 |
| Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) (NCT01110876) | M.D. Anderson Cancer Center | 2011-06-01 |
| Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas (NCT01058850) | Paul Graham Fisher | 2011-06-01 |
| A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients (NCT01770626) | University of Alabama at Birmingham | 2011-04-01 |
| EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas (NCT01257594) | Andrew B Lassman, MD | 2011-01-07 |
| Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme (NCT01205334) | Baylor College of Medicine | 2010-11-01 |
| Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma (NCT01105702) | NYU Langone Health | 2010-05-01 |
| TPI 287 in Patients With Recurrent Glioblastoma Multiforme (NCT01113463) | M.D. Anderson Cancer Center | 2010-04-01 |
| Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) (NCT01067469) | M.D. Anderson Cancer Center | 2010-01-01 |
| Optimal Planning Target Volume With Stereotactic Radiosurgery (NCT01017497) | Duke University | 2009-12-01 |
| Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors (NCT01014767) | Tufts Medical Center | 2009-11-01 |
| Image-Guided Stereotactic Biopsy of High Grade Gliomas (NCT00979810) | Memorial Sloan Kettering Cancer Center | 2009-09-16 |
| Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma (NCT00883688) | M.D. Anderson Cancer Center | 2009-07-01 |
| Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer (NCT00946673) | Stanford University | 2009-06-01 |
| Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases (NCT00928226) | Stanford University | 2009-04-01 |
| Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer (NCT00871923) | M.D. Anderson Cancer Center | 2009-03-26 |
| Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors (NCT00870129) | Memorial Sloan Kettering Cancer Center | 2009-03-01 |